#United States #Kuehn Law #Shareholder Rights #Southampton #Picard Medical

Kuehn Law Investigates Alleged Misconduct by Picard Medical Inc.

In a significant move that has sent ripples through the investment community, Kuehn Law, PLLC, a notable firm specializing in shareholder litigation, has announced an investigation into potential fiduciary breaches by certain officers and directors of Picard Medical Inc., a company listed on the NYSE AMERICAN under the symbol PMI.

The investigation centers around claims made in a federal securities lawsuit that insiders at Picard Medical may have engaged in serious misconduct. Allegations surfaced suggesting that the company misrepresented crucial information to shareholders, creating a potentially deceptive portrayal of its financial health and market activities.

Allegations of Fraudulent Practices

According to the lawsuit, key insiders of Picard Medical were involved in a fraudulent stock promotion scheme. This scheme reportedly utilized misinformation spread across social media platforms and involved impersonating financial professionals. Such actions are believed to have contributed significantly to misleading the public and investors about the true nature of the company's operations and stock performance.

The suit claims that these insiders, or their affiliates, allegedly utilized offshore or nominee accounts. This facilitated a coordinated effort to dump shares during a forced price inflation campaign. Furthermore, investors were not informed about the artificial trading activities that significantly affected the stock price, nor were they made aware of the false rumors that circulated, impacting their investment decisions.

Who Should Act

If you are an investor in Picard Medical Inc. and acquired shares before September 2, 2025, Kuehn Law urges you to get in touch. This outreach is critical as there may be limited time for shareholders to enforce their rights. The firm, which does not charge its clients for litigation costs, emphasizes the importance of participants taking action now to ensure their voices are heard.

J. Sophia Anne Silayan, reaching out via email or by phone at (833) 672-0814, is leading the communication and support for concerned shareholders. Kuehn Law is committed to representing the rights of their clients without upfront litigation costs, reinforcing their aim to uphold the integrity of financial markets.

The Importance of Speaking Up

Engaging with this investigation is essential not just for affected investors but for the broader principle of maintaining fairness within the financial markets. The message from Kuehn Law is clear: every shareholder's voice matters. By taking action, you contribute to fostering an investment atmosphere where transparency and accountability are paramount.

Conclusion

The unfolding situation surrounding Picard Medical Inc. reflects broader concerns regarding corporate governance and investor rights that are increasingly vital in today’s financial landscape. Kuehn Law invites any impacted investors to join the cause for fairness and rightful representation. For further details, potential clients can visit their website for extensive resources related to shareholder derivative litigation.

The landscape of corporate investment is fraught with both risks and rewards, and in these moments, the role of vigilant legal counsel becomes instrumental. As investigations progress, the focus will remain on ensuring that investors are safeguarded against misleading and unethical practices.

• ---

Contact Information:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
Email: [email protected]
Phone: (833) 672-0814